itim Group – ‘Retail Engineers’ Report Positive Interims And Strong Cash Generation, Broker Ups Estimates 

Yesterday’s Interim Results from the itim Group (LON:ITIM) were better than expected. 

The group, which is a SaaS based technology company that enables store-based retailers to optimise their businesses to improve their efficiency, effectiveness and financial performance, reported revenues up 19% in the first half year to end-June. 

In reaction the group’s shares put on a useful 18% advance in price, to 41.50p, valuing it at only £12.95m. 

The Business 

Established in 1993 by its founder, and current Chief Executive Officer, Ali Athar, was initially formed as a consulting business, helping retailers to effect operational improvement.  

From 1999 the company began to expand into the provision of proprietary software solutions and by 2004 it was focused exclusively on digital technology.  

Over the years it has grown both organically and through a series of acquisitions of small, legacy retail software systems and associated applications, which the group has redeveloped to create a fully integrated end-to-end ‘omnichannel’ platform. 

That platform enables retailers to adopt an engaging customer-centric approach to shopping in-store, online and on mobile.  

Its retail software solutions support multi-channel sales and service, enterprise order management, price and stock optimisation, and supplier management. 

Today the company works with over 80 retailers across 11 countries, a small range of its clients includes: Whitbread, Majestic Wine, Argos, The Entertainer, John Lewis, Sainsbury’s, The Fragrance Shop, Costa Coffee, JC Penney, Walmart, McDonalds, Quiz, Co-Op, Waitrose, WH Smith, and Travis Perkins. 

It provides ‘omnichannel’ retailers with a ‘Unified Retail’ platform designed around the customer, that leads to increased sales and profitability. 

The Equity 

There are some 31.2m shares in issue. 

Larger holders include the Athar family (38.40%), Lewis family (18.07%), Robert Frosell, Dir (7.64%), Herald Investment Management (6.37%), Curtis family (4.12%), Ian Hayes, Dir (2.72%), Michael Jackson, Dir (1.76%), Sandra da Costa Ribeiro, Dir (0.87%) and Justin King (0.74%). 

Analyst Views 

John Cummins and Charlie Cullen yesterday upped their estimates for the current year to end-December to look for revenues of £17.1m (£16.1m), and an adjusted pre-tax loss of £0.7m (£1.1m loss).  

The analysts were previously expecting a £1.0m loss this year, so the small improvement is noteworthy. 

They were also anticipating that the company would end this year with £0.5m cash in the bank, but now they have adjusted their figures to seek a useful £2.1m cash at year-end. 

For 2025 they foresee £18.0m sales, and a turn around into £0.4m profits, worth 1.9p per share in earnings per share. 

They note that with an encouraging pipeline of business leading into next year, they view the company as very well placed to continue to deliver into FY2025 and see substantial room for upside as new contracts are secured.   

The analysts have previously stated that they consider that this group’s shares were trading on an undemanding rating compared to their ‘fair value’ of 55p a share. 

In My View 

Capitalised at only £12.95m, even with its shares 18% better yesterday at 41.50p, it will have £2.1m cash in the bank at the year-end. 

I can see the broker’s analyst price estimates as being easily achieved in due course. 

Tekcapital hints at Guident IPO as NAV surges higher in first half

Tekcapital shares were higher in early trading on Wednesday after the technology group announced a 46% jump in NAV and hinted at the IPO of portfolio company Guident.

“We are excited to report significant progress across our portfolio companies. This has resulted in the growth of our Net Assets during the period by ~ 46% reaching US$69.8m with an NAV per share of US$0.35,” said Dr. Clifford M. Gross, Tekcapital Chairman.

“Our first half performance reflects strong commercial progress of the portfolio companies during the period. I’m delighted that each portfolio company has grown its respective revenues this year, validating our investment case for each company and the Tekcapital investment process.”

Microsalt, the low-sodium technology company, accounted for a large proportion of the NAV gains after it listed in London in February this year. The company has agreements with one of the world’s largest snack foods businesses to supply low-sodium salt, as well as extensive retail distribution channels.

Following MicroSalt’s successful listing earlier this year, Tekcapital is moving forward with its strategy of creating shareholder value through achieving portfolio company liquidity events by launching AI analytics company GenIP.

“As part of our strategy to create value from innovative technologies, we launched GenIP this summer. We feel its forthcoming IPO will provide UK-focused investors with a unique opportunity to secure exposure to the fast-growing Generative AI analytics market,” Gross said.

The surprise proposed GenIP IPO will add around £5m of liquid NAV to the portfolio.

Guident IPO

Investors who see Guident as the jewel in Tekcapital’s crown will be delighted to see the Tekcapital group Chairman hint at a listing after noting revenue-generating progress for the autonomous vehicle safety company.

“Guident has made material progress in commercialising its autonomous vehicle safety solutions, and revenue generation has increased accordingly,” Gross said.

“We believe improving market conditions and Guident’s commercial advancements are creating the ideal opportunity for Tekcapital to crystalise the balance sheet value held in the company while providing a greater pool of investors the chance to join us in the next phase of Guident’s scale-up. As previously announced, Guident is seeking a private investment round and, once consummated, should have the investor support for a range of possible future funding opportunities, including an initial public offering.”

Guident has plenty of space for a higher valuation on listing given the size of the addressable market and Guident’s SaaS model, which provides recurring revenues.

Portfolio management

In this update, Tekcapital alluded to taking a measured approach to managing its portfolio. Although nearly all of Tekcapital’s technology companies are now listed, the company clearly still has a desire to capture new opportunities.

Interestingly for investors, the Tekcapital board has also displayed flexibility in their approach to creating value for shareholders, which is likely to expedite returns. The company has previously opted to found companies and provide seed capital directly into them. The approach to GenIP is different because the first major funding round is the upcoming IPO.

This does two things. First, it allows investors to gain exposure to the company in the early stages when the company grows rapidly. Second, it reduces reliance on Tekcapital for growth capital.

Dr Clifford Gross said that the company is at ‘an inflection point’ and shares have reacted accordingly on Wednesday.

AIM movers: Ondine Biomedical raises money at a premium and Itim breaks even in the first half

0

Ondine Biomedical Inc (LON: OBI) has raised £2.8m at 12.5p/share, although the transaction is not expected to be completed until early November. This follows a partnership with Sweden-based Molnlycke Health Care that will take the Steriwave nasal antimicrobial treatment in the European and Middle East markets. The UK is the initial focus. The addressable market is $300m. The share price improved 26.7% to 7.125p.

Retail software developer Itim Group (LON: ITIM) managed to breakeven in the first half of 2024 on a 19% increase in revenues to £8.8m. Net cash is £3m. Zeus upgraded its 2024 expectations to a loss of £700,000, down from £1m. Net cash should be £2.1m at the end of 2024. The share price rose 18.6% to 41.5p.

Mortgage Advice Bureau (LON: MAB1) improved interim revenues by 5% to £123.9m, while underlying pre-tax profit was two-fifths ahead to £12.3m. The interim dividend is maintained at 13.4p/share. The market share for new mortgage lending edged up from 8.2%. Revenue per adviser was 9% higher. After a weak second quarter there are signs of demand gradually building. New case numbers are 11% ahead in July and August. The share price increased 6.43% to 579p.

Investment company Seed Innovations (LON: SEED) says it is optimistic about its investment portfolio and it had £3.5m in cash at the end of August. Cash alone covers the market capitalisation, while estimated NAV is £10.8m. The share price is 10.3% higher at 64p.

FALLERS

Corcel (LON: CRCL) says 90%-owned Atlas Petroleum Exploration Worldwide has authorisation for the assignment of an additional 20% interest in operated block KON-16, onshore Angola. Apex will have a 55% interest. Corcel has raised £1.22m at 0.1p/share. The share price slipped 21.2% to 0.1025p.

Clontarf Energy (LON: CLON) has raised £450,000 at 0.045p/share. The cash will be invested in the Bolivian lithium interests. The share price fell 12.2% to 0.0505p.

Scancell (LON: SCLP) reported a pre-tax loss of £9.1m in the year to April 2024 following an increase in research and development spending. Net cash is £14.8m and that could fall to £4.7m by the end of April 2025. Scancell is expected to release data on three different cancer vaccines in the next nine months. The share price declined 6.67% to 14p.

Manx Financial (LON: MFX) reported interims showing a 16% increase in pre-tax profit to £3.5m. The net loan book grew and that offset lower net interest income. The board believes that the second half will be less positive than the first half. The share price dipped 3.13% to 15.5p.

FTSE 100 jumps after additional Chinese stimulus

Chinese stimulus helped propel the FTSE 100 higher on Tuesday as the world’s second-largest economy stepped up its efforts to support the economy.

China has taken a different approach to the slowing economy over the past year by holding back from major stimulus and choosing to let events play out – much to the displeasure of investors who had become accustomed to China acting at the first sign of weakness.

However, China’s stuttering growth has proved too much for Beijing, which again moved to stimulate the economy overnight, sending Asian stocks soaring.

“China has been searching for solutions to its economic growth challenge for some time, and stimulus measures haven’t really worked. It’s gone from being a trailblazer with supersonic economic expansion to a country whose batteries were close to running out of energy. It’s now gone all-in with its bet on getting the economy back into top gear and that’s driven the mother of all rallies on the Chinese stock market,” said Russ Mould, investment director at AJ Bell.

China chose to focus on the much-loved housing market for the latest major stimulus to help the struggling industry after years of slow growth and debt troubles.

“The People’s Bank of China has delved into its bag of tricks to try to get growth back to the 5% target, including cuts to interest rates, mortgage rates, and downpayments for house buyers,” said Matt Britzman, senior equity analyst, Hargreaves Lansdown.

The focus on housing plays straight into the Chinese wealth effect and the historical investment case for the country as a consumer of natural resources.

“The Shanghai SSE index jumped 4.15% while the Hang Seng soared by 4%, indicating that investors are pleased with plans to lower borrowing costs and allow banks to increase their lending. That had a direct read-across to the FTSE 100 and its army of commodity producers who should benefit from greater economic activity in China and for London-listed companies which do business with consumers in the country including Burberry and Prudential,” Russ Mould said.

The miners are almost always the biggest beneficiaries of Chinese stimulus, and on Tuesday, Antofagasta, Rio Tinto, and Anglo American were all among the top gainers. 

Smiths Group was the top faller, down 7%, after releasing lacklustre full year results.

CleanTech Lithium – ASX Dual-Listing Process Slowed Down By ‘Procedural Matters’ Sees Shares Gyrate 

Plans are currently being delayed by ‘procedural matters’ in this group’s application for a listing on the Australian Securities Exchange. 

On Tuesday 13th August the hopes were that CleanTech Lithium (LON:CTL) had submitted its Prospectus for a dual-listing on the ASX. 

It also inferred that it was hoping to raise up to A$20m in the process. 

Management Comment 

At that time Chairman and Interim CEO Steve Kesler stated that: 

“CleanTech Lithium is positioning itself to become a leading supplier of battery-grade lithium to the growing EV and energy storage market to support the global energy transition. 

We’re excited of the prospect to join the ASX which is home to many of the world’s leading lithium companies. 

In addition to our existing AIM listing, the dual-listing in Australia will provide us with access to a broader collection of security holders and stakeholders who have a deep understanding of the lithium industry and its importance in supporting the world’s ambitions for net-zero.  

We are looking forward to introducing CTL to the Australian market, providing Australian investors the opportunity to invest in an emerging producer of battery grade lithium from a country with an established lithium industry, an FTA with the USA and a preferential trade agreement with the EU. 

Our two core projects host, in aggregate, total resources of more than 2.7 million tonnes of LCE and we are advancing the use of DLE technology, which features much higher recovery rates and less environmental impact compared to conventional forms of lithium extraction.  

We are also aiming to be powered by renewable energy once in production, utilising Chile’s excellent renewable energy resources including in the region of our projects. 

Harnessing DLE and renewable energy positions CTL to be a leader in a more efficient method of producing lithium in Chile, and we believe this will give us an advantage in supplying a premium lithium product to the market.” 

The company declared that the proceeds of the proposed Fundraising could be applied towards the development of the company’s suite of projects in Chile, primarily the completion of the Pre-Feasibility Study at the Laguna Verde Project and ongoing operations at the DLE pilot plant, which is producing battery-grade lithium carbonate.  

CTL’s projects are centred in an area of northern Chile dubbed the ‘lithium triangle’ which is shared with Argentina and Bolivia.  

CTL aims to become a leading producer and supplier of ‘green’ battery-grade lithium to the Electric Vehicle and Energy Storage market by utilising advanced environmentally-sensitive processing technology powered by renewable energy. 

Submission Of Replacement Prospectus 

On Tuesday 27th August the group announced that it had needed to issue a Replacement Prospectus to the ASX clarifying the scalability and global usage of Direct Lithium Extraction and the company’s reliance on renewable energy and potential exposure to fossil fuels.  

The amended copy now also contains additional information on the Chilean national electricity grid’s existing high renewable energy mix.  

It noted that it plans, where possible, to include renewable energy sources to power operations in line with its objective of promoting sustainable lithium production. 

At that time the company stated that it did not anticipate that the lodgement of the Replacement Prospectus would impact the timing of its admission to ASX and declared that admission is expected to occur on or around 24th September. 

Offer Period Extended 

On Monday 9th September the company noted the delay and reactively decided to extend the Offer Period for its fundraising from 9th September to 23rd September. 

It stated that it will provide a further update once it has received confirmation of the proposed ASX Admission and commencement of trading dates.  

Update On Its ASX Listing 

Last Friday 20th September the company announced that it had been informed by representatives of the Australian Securities Exchange that due to procedural matters the approval process of the company’s listing on ASX will be extended. 

CleanTech Lithium informed investors that it is working with its lawyers in Australia, its other advisers and ASX to address the matters expeditiously and will provide the market with a further update when greater clarity has been obtained on the revised expected timetable. 

In My View 

This £23m capitalised group’s shares, which hit 94p in February last year and were down to just 10.50p in April this year, before rapidly picking up to 25.30p in late July, then drifted back to 14p just over a month ago. 

Despite the ‘procedural delays’ they are now trading at around the 15p level. 

I hope that the company can get its ASX listing speeded up, thereby enabling the required funding to complete. 

Getting that out of the way will allow mining sector punters to react rapidly to any items of good corporate news that are sure to follow. 

Should you buy an S&P 500 ETF now?

Should I buy an S&P 500 ETF at current levels? There’s no two ways about it, for many investors, buying the S&P 500 index is probably the best thing they could do if they’d like to get exposure to the stock market.

The numbers are compelling. The S&P 500 has outperformed most active managers by some margin over the past decade. 

However, while this fact is often touted by ETF proponents, it doesn’t take into consideration that private investors can be a lot more nimble than your average fund manager, apply a degree of trading to their portfolios, boosting returns.

That is, of course, if they have the experience to do so. Those who don’t have a reasonable level of experience in the stock market are probably better suited to sticking to the broader equities indices.

Investors in the S&P 500 index will gain exposure to the world’s largest companies. Household names such as Apple, Microsoft, Nvidia, and Amazon make up a large proportion of the index and, therefore, your investment when you buy an S&P 500 index ETF.

These companies and the S&P 500 have been a safe bet and will likely remain so for the foreseeable future. 

There is one technique that savers and investors should be aware of to help smooth out the inevitable bumps in the road when investing in stocks. 

That’s dollar cost averaging. Or pound cost averaging, depending on which side of the Atlantic you’re on.

The answer to our question of whether you should buy an S&P 500 ETF at current levels is probably yes. But it will also be yes at the same time next month, and the month after that, and, yes, the month after that.

By drip-feeding your cash into the S&P 500 on a regular basis, you even out your investment and soften any bouts of volatility. They even become an opportunity and can boost your long-term returns.

Who knows if the S&P 500 will be 5% higher or lower next month? With dollar cost averaging, it doesn’t matter; you buy anyway. It builds your investment and smooths out the entry points.

Raspberry Pi EBITDA soars as supply recovers

Fresh after London’s largest technology IPO of 2024, the computing and technology company announced a solid set of first half results on Tuesday. Raspberry Pi raised $179m in June this year.

Despite marginally lower volumes than the comparative period, Raspberry Pi’s overall performance was better than expected during the period. 

EBITDA was 55% higher in H1 2024 than in H1 2023 due to issues with supply in the first half of last year which made this year’s number look that much better.

Investors will also be encouraged to hear that the company sees higher volumes in the second half. 

“The IPO was the watershed moment of the first half, with Admission to trading just two weeks before the period end,” said Eben Upton, CEO of Raspberry Pi.

“In continued pleasing trading in the first half, we saw strong uptake of our latest flagship SBC, Raspberry Pi5, the launch of the Raspberry Pi AI Kit, and the successful ramp to production of RP2350, our second-generation microcontroller platform. The higher than usual customer and channel inventory levels which were evident at the time of the IPO have continued to unwind, and there is a growing sense that this will have concluded by the year end.

“We have an extraordinary team, a world class product set backed up by an exciting future roadmap, and a loyal and engaged customer base that we can continue to grow. In the second half, we have further planned product releases and a number of initiatives to further expand our engagement within our Industrial and Embedded market”.

Antofagasta shares: FTSE 100 mining pick for a recovery in copper prices and the green transition

Antofagasta shares are supported by long-term structural economic expansion and the demand for copper from the clean energy transition.

After touching highs above $10,000 per tonne earlier this year, copper prices have gently eased amid concerns about Chinese growth. However, the Federal Reserve’s decision to start cutting interest rates has sparked a rally in the copper, which touched two-month highs last week. 

Copper’s high correlation with the underlying growth environment has earned the metal the title ‘Dr Copper’, as a rise in the price of metal is usually caused by improving sentiment or economic expansion.

It remains to be seen whether the recent rally in copper is just a result of improving sentiment after the Fed cuts interest rates or is a predictor of future economic buoyancy. Indeed, the shift in copper’s narrative to US interest rates away from Chinese growth will likely be short-lived.

That said, if we see any signs of positivity from China in the coming months, copper prices have plenty of space to rally.

In addition to immediate macroeconomic considerations for the price of copper, the metal is set to benefit from long-term structural demand from the green energy transition. For all the furore around lithium, cobalt, and uranium, copper is the essential metal at the heart of most green energy technologies, including electric vehicles and power generation.

Investors seeking exposure to further recovery in the price of copper or would like to position for the green transition without buying futures or trading another form of derivative should look no further than Antofagasta.

FTSE 100-listed Antofagasta is the ultimate play on copper prices for UK-focused equity investors. The company’s resource base is around 21 billion tonnes, making it one of the world’s leading copper miners in terms of resources.

Focused on Chilean copper assets, Antofagasta’s strength lie in extensive production operations and the supportive environment for copper prices.

Antofagasta invested in mining operations at a time when capital costs were much lower. This provides investors with the attractive advantage of an upside in copper prices without the CAPEX required to bring mines online.

It has become hugely expensive to construct new mines, leading to a dearth of new mines coming on line. It’s one thing for early-stage companies to identify economically viable resources; securing the funds to extract them is something entirely different, especially at the scale at which Antofagasta is operating.

Antofagasta produced 284,000 tonnes of copper in the six months to the end of June 2024. Although this was slightly lower than in the same period last year, group revenues rose 2% due to a higher comparative copper price.

The company expects to spend $2.7bn in capital expenditure for the full year. A large proportion of this will be allocated to improving facilities to increase copper production.

Antofagasta has plentiful resources in place, and its growth strategy is to increase the pace at which it is monetised. Very few miners have the mineral or capital resources to achieve the levels of production Anto is targeting, giving it a huge competitive advantage.

Investors should also note the company’s willingness to return cash to shareholders. Antofagasta pays out 35% of underlying earnings per share. This policy means payouts can be volatile, but it leaves plenty of opportunity for substantial payouts on periods of good performance. 

In conclusion, the stock offers robust chances of both capital growth and income, and with shares below 2,000p, it should be on the watch list of any natural resources fan. 

Transense Technologies potential starts to be recognised

Investors are starting to recognise the potential of Transense Technologies (LON: TRT) and it is building up a range of potential users for its surface acoustic wave technology. The share price has risen by nearly three-quarters so far this year.
Royalty income from Bridgestone for the iTrack monitoring technology continues to grow and provide cash flow for investment in the SAWsense business, which is still at an early stage of developing products for potential clients. Translogik tyre management operations also provide cash flow.
In the year to June 2024, group revenues improved from £3.53m ...

AIM movers: Oxford Metrics contract delays and Electric Guitar wins business in Singapore

10

Electric Guitar (LON: ELEG) says subsidiary 3radical has won a campaign with Singapore-based media network Mediacorp. This follows a test period where 3radical’s Voco engagement platform was used to capture customer data on the Mediacorp website. The focus will be behavioural data. The share price rebounded 8.33% to 0.65p.

Telematics services provider Microlise (LON: SAAS) has secured a five-year contract renewal with JC Bamford up until September 2029. The technology enhances connectivity and diagnostic capabilities to improve productivity. The relationship has lasted 14 years. The share price rose 6.22% to 128p.

Exploration data services provider Getech (LON: GTC) interim revenues were 17% ahead at £2.2m and annualised recurring revenues are £2.9m. Even excluding exceptional costs, the loss was reduced from £2.19m to £733,000. The cash position was improved by the £1.7m fundraising in August. The full year loss should be lower and Getech could move back into profit in 2025. The share price improved 3.7% to 2.8p.

Challenger Energy (LON: CEG) has received Uruguay government approval for its OFF-1 farm out to Chevron. The deal should be completed within eight weeks and Chevron will pay $12.5m. Chevron will then become operator and start the seismic campaign in early 2025. These costs are covered by Chevron, which will own 60% with Challenger Energy holding 40%. There are three identified prospects on OFF-1. Zeus has a risked NAV of 28p/share. The share price increased 2.46% to 6.25p.

FALLERS

Spirits supplier Distil (LON: DIS) is raising £650,000 at 0.12p/share with non-exec Roland Grain subscribing £200,000 and Dr Graham Cooley £90,000. The shares come with placing warrants exercisable at 0.36p each. Allenby has been appointed as broker. The cash will fund promotion and production of stock. The share price slid 27.5% to 0.145p.

Vast Resources (LON: VAST) says that if A&T Investments takes enforcement procedures against a third party that has secured the $5.82m debt owed by Vast Resources this will not have any immediate effect on the business. Management is seeking ways of raising additional finance to settle debts. The share price slumped 24.4% to 0.0775p.

Smart sensing software developer Oxford Metrics (LON: OMG) has been hit by the weak video games sector and delays to business. Full year revenues will be between £40m and £42m, compared with £48.6m previously. Pre-tax profit of £7.78m was previously expected, but the outcome will be much lower. There is still £50m in the bank, which underpins the market capitalisation of £82.8m and provides funding potential acquisitions. The share price dived 20.5% to 63p.

Software and maintenance services provider Pennant International (LON: PEN) says that the UK strategic defence review has led to delays in training contracts. This part of the business is being reviewed with plans to focus on a software-led model. Interim revenues were 4% higher at £7.4m despite a decline in North American revenues because of the splitting up of a large Canadian contract. There was a move back into a modest profit. A new software product will be launched in early 2025. Cavendish still expects a full year loss of £400,000, but it is reviewing its 2025 figures. The share price declined 13% to 23.5p.